Trump admin set to announce using Tylenol while pregnant could raise autism risk
President Trump plans to announce Monday that using Tylenol while pregnant could potentially raise the risk of developing autism, sources told The Post.
The Trump administration is expected to start advising pregnant women against using the over-the-counter pain medication unless they have high fevers, those familiar with the announcement said.
Officials are also slated to reveal efforts to explore using leucovorin — a drug used for cancer and anemia — to treat those with autism, the sources added.
Trump has been touting a looming announcement tied to the neurological condition for several days.
“I think we found an answer to autism,” he said on Sunday during a speech at conservative influencer Charlie Kirk’s funeral.
“I think it’s going to be one of the most important news conferences I’ll ever have, and I look so forward to it.”
Autism affected about one in 31 8-year-olds in the US in 2022, according to the latest Centers for Disease Control and Prevention data.
The announcement will mark the first time the US government has linked acetaminophen to autism.
It wasn’t immediately clear what research the administration will cite.
Researchers at the Icahn School of Medicine at Mount Sinai dropped a study last month that showed prenatal exposure to the pain relief medication could potentially increase the risk of neurodevelopmental disorders, including autism and ADHD in children.
“Our findings show that higher-quality studies are more likely to show a link between prenatal acetaminophen exposure and increased risks of autism and ADHD,” Dr Diddier Prada, one of the researchers, said at the time.
“Given the widespread use of this medication, even a small increase in risk could have major public health implications.”
The study did not determine that acetaminophen use could directly cause neurodevelopmental disorders in kids.
Health Secretary Robert F. Kennedy Jr. has long vowed to make autism a priority and last month teased an upcoming report on the disorder.
“We are using gold-standard science to get to the bottom of America’s unprecedented rise in autism rates,” a Health and Human Services spokesperson said at the time.